The co-chairs of the writing committee for the “2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease” answer our questions about the updated guideline and why aspirin is no longer...
Dr Stephen Kopecky from Mayo Clinic talks about his 3 sessions at the ASPC's 2018 Congress: CV biomarkers, lipid testing, managing atrial fibrillation with anticoagulation therapy, and the effect of...
In this article Michael J. Bloch, MD, writes about the potential use of a polypill for cardiovascular disease prevention and discusses how the results of recent research supports the potential use in the...
